Tirzepatide, the active ingredient in Mounjaro, is a dual GIP/GLP-1 receptor agonist
The Green List is FDAs trusted lane for GLP1 API manufacturers FDA calls 6680 a green list import alert in its consumer-facing GLP1 warning page
If you are taking a GLP-1 drug and feel pain in your belly, have trouble swallowing, or feel heartburn often, talk to your doctor
In contrast, Nrf2 activators, such as sulforaphane, have been found to prevent homocysteine- or hydrogen peroxide-induced cataract formation in human lens epithelial cells by increasing nuclear translocation of Nrf2 and expressions of cellular antioxidants, including catalase, superoxide dismutase, glutathione peroxidase, and glutathione
When you reconstitute the peptide, you should never shake the vial vigorously
The FTCs ongoing investigation into PBM market practices and the Amgen verdict establishing limits on bundling suggest that fully exclusionary formulary policies favoring PBM-owned products may face antitrust scrutiny